What is Scientus Pharma?
Scientus Pharma operates as a sophisticated, vertically-integrated biopharmaceutical enterprise dedicated to the scientific exploration and commercialization of cannabinoid derivatives. By maintaining dual status as a Licensed Producer under the Cannabis Act and a Licensed Dealer under the Narcotics Control Act, the company occupies a unique niche in the life sciences sector. Its operational model prioritizes the synthesis of pharmaceutical-grade products, bridging the gap between raw botanical research and clinical-grade therapeutic applications. This dual-licensing strategy provides the firm with a distinct competitive advantage, allowing for comprehensive control over the supply chain and research pipeline, which is essential for navigating the complex regulatory landscape of the pharmaceutical industry.
How much funding has Scientus Pharma raised?
Scientus Pharma has raised a total of $11.5M across 1 funding round:
Debt
$11.5M
Debt (2017): $11.5M with participation from Aphria Inc
Key Investors in Scientus Pharma
Aphria Inc
A prominent Canadian producer and supplier of medical cannabis, focused on large-scale cultivation and distribution within the regulated healthcare market.
What's next for Scientus Pharma?
Looking ahead, the recent capital injection is expected to accelerate the company's research and development initiatives, specifically targeting the expansion of its proprietary cannabinoid derivative portfolio. As the firm transitions into a more mature operational phase, the focus will likely shift toward scaling its manufacturing capabilities and advancing clinical trials to meet stringent international pharmaceutical standards. By leveraging its existing infrastructure and regulatory credentials, Scientus Pharma is well-positioned to capitalize on the increasing demand for evidence-based cannabinoid therapies. The strategic deployment of these funds will be critical in maintaining its trajectory as a leader in the biopharmaceutical space, ensuring that the company remains at the forefront of innovation while navigating the evolving global regulatory environment for controlled substances.
See full Scientus Pharma company page
